These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7261840)

  • 1. Sulfamethoxazole-induced hepatic injury.
    Steinbrecher UP; Mishkin S
    Dig Dis Sci; 1981 Aug; 26(8):756-9. PubMed ID: 7261840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic injury in a child caused by trimethoprim-sulfamethoxazole.
    Stevenson DK; Christie DL; Haas JE
    Pediatrics; 1978 Jun; 61(6):864-6. PubMed ID: 673549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of sensitized lymphocytes to trimethoprim/sulfamethoxazole and ofloxacin in a patient with cholestatic hepatitis.
    Hofer T; Becker EW; Weigand K; Berg PA
    J Hepatol; 1992 May; 15(1-2):262-3. PubMed ID: 1506646
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cholestasis caused by co-trimoxazole. Presentation of a new patient and review of the literature].
    Acero D; Masabeu A; Alabern C; Oterino A
    Rev Esp Enferm Apar Dig; 1985 Aug; 68(2):169-73. PubMed ID: 3877957
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrahepatic cholestasis and phospholipidosis associated with the use of trimethoprim-sulfamethoxazole.
    Muñoz SJ; Martinez-Hernandez A; Maddrey WC
    Hepatology; 1990 Aug; 12(2):342-7. PubMed ID: 2167870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute liver failure and severe cholestasis due to sulfonamides].
    Horák J; Mertl L; Hrabal P
    Cas Lek Cesk; 1985 Feb; 124(6):185-7. PubMed ID: 3871662
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of drug-induced recurrent cholestatic hepatitis].
    Pavlova MV; Natov SN; Badev IR
    Ter Arkh; 1989; 61(2):125-7. PubMed ID: 2786261
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic toxicity associated with gold therapy.
    Favreau M; Tannenbaum H; Lough J
    Ann Intern Med; 1977 Dec; 87(6):717-9. PubMed ID: 412451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole.
    Kouklakis G; Mpoumponaris A; Zezos P; Moschos J; Koulaouzidis A; Nakos A; Pehlivanidis A; Iosiphidis M; Molyvas E; Nikolaidis N
    Ann Hepatol; 2007; 6(1):63-5. PubMed ID: 17297432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestatic and hepatocellular injury associated with erythromycin esters: report of nine cases.
    Zafrani ES; Ishak KG; Rudzki C
    Dig Dis Sci; 1979 May; 24(5):385-96. PubMed ID: 456225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonamide-induced chronic liver disease.
    Tönder M; Nordöy A; Elgjo K
    Scand J Gastroenterol; 1974; 9(1):93-6. PubMed ID: 4453809
    [No Abstract]   [Full Text] [Related]  

  • 13. Simultaneous occurrence of toxic hepatitis and Stevens-Johnson syndrome following therapy with sulfisoxazole and sulfamethoxazole.
    Shaw DJ; Jacobs RP
    Johns Hopkins Med J; 1970 Mar; 126(3):130-3. PubMed ID: 5438369
    [No Abstract]   [Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole-induced cholestatic hepatitis. Inadvertent rechallenge.
    Thies PW; Dull WL
    Arch Intern Med; 1984 Aug; 144(8):1691-2. PubMed ID: 6331808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentin-induced jaundice with a fatal outcome.
    Hebbard GS; Smith KG; Gibson PR; Bhathal PS
    Med J Aust; 1992 Feb; 156(4):285-6. PubMed ID: 1738330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drugs and the liver].
    Sherlock S
    G Clin Med; 1970 Oct; 51(10):753-9. PubMed ID: 5523586
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholestatic hepatitis after administration of furan derivatives.
    Engel JJ; Vogt TR; Wilson DE
    Arch Intern Med; 1975 May; 135(5):733-5. PubMed ID: 150825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole.
    Dujovne CA; Chan CH; Zimmerman HJ
    N Engl J Med; 1967 Oct; 277(15):785-8. PubMed ID: 6046676
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrahepatic cholestasis due to trimethoprim-sulfamethoxazole.
    Coto H; McGowan WR; Pierce EH; Thomas E
    South Med J; 1981 Jul; 74(7):897-8. PubMed ID: 7256343
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulfonamide hepatitis. Report of a case due to sulfamethoxazole and sulfisoxazole.
    Fries J; Siragenian R
    N Engl J Med; 1966 Jan; 274(2):95-7. PubMed ID: 5901208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.